home · filing · 0001104659-22-004478
8-K filed January 14, 2022, 6:59 PM ET
ticker MTVA
CIK 0001638287
leadership
confidence high
sentiment neutral
materiality 0.20
NeuroBo board member Swirsky resigns; Koven elected Chairman, Salsbury joins Audit Committee
MetaVia Inc.
Douglas J. Swirsky resigned from board effective Jan 14, 2022; no disagreement with company.
Andrew I. Koven elected Chairman of the Board.
Michael Salsbury appointed to Audit Committee and as Chairman of Audit Committee.
Audit Committee now consists of Jason Groves, Andrew I. Koven, and Michael Salsbury; all deemed independent.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Role change
Andrew I. Koven
Chairman of the Board
Effective 2022-01-14
Filed January 14, 2022, 6:59 PM ET
Andrew I. Koven, a current director of the Company was elected Chairman of the Board
Departed
Douglas J. Swirsky
Director
Effective 2022-01-14
Filed January 14, 2022, 6:59 PM ET
Mr. Douglas J. Swirsky provided notice of his resignation from the Board of Directors
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andrew I. Koven was elected as Chairman of the Board at MetaVia Inc..
Action elected
Role Chairman of the Board
Exact text from the filing
Andrew I. Koven, a current director of the Company was elected Chairman of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Douglas J. Swirsky resigned as Director at MetaVia Inc..
Action resigned
Role Director
Exact text from the filing
Mr. Douglas J. Swirsky provided notice of his resignation from the Board of Directors
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-22-004478
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.